Heterogenous origins of hyperandrogenism in the polycystic ovary syndrome in relation to body mass index and insulin resistance

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Gynecological Endocrinology

• Publication date

  2018-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/09513590.2017.1393062PMID 29068242
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ReviewPolycystic ovary syndrome : a complex condition with psychological , reproductive and metabolic manifestations that impacts on health across the lifespan

  2015cited by this paper
• Adrenal androgen excess and body mass index in polycystic ovary syndrome.

  2015cited by this paper
• A cross-sectional study of polycystic ovarian syndrome among adolescent and young girls in Mumbai, India

  2014cited by this paper
• Global adiposity and thickness of intraperitoneal and mesenteric adipose tissue depots are increased in women with polycystic ovary syndrome (PCOS).

  2013cited by this paper
• Clinical review: Adolescent anovulation: maturational mechanisms and implications.

  2013cited by this paper
• Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis.

  2012cited by this paper
• Opposing effects of dehydroepiandrosterone sulfate and free testosterone on metabolic phenotype in women with polycystic ovary syndrome.

  2012cited by this paper
• CHAPTER 17 – Physiology and Pathology of the Female Reproductive Axis

  2011cited by this paper
• Prevalence of polycystic ovary syndrome in a sample of Indigenous women in Darwin, Australia

  2011cited by this paper
• Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria.

  2010cited by this paper
• POLYCYSTIC OVARY SYNDROME Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome

  2009cited by this paper
• Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome.

  2009cited by this paper
• The investigation and management of severe hyperandrogenism pre- and postmenopause: Non-tumor disease is strongly associated with metabolic syndrome and typically responds to insulin-sensitization with metformin

  2008cited by this paper
• A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs.

  2008cited by this paper
• Prevalence and metabolic characteristics of adrenal androgen excess in hyperandrogenic women with different phenotypes

  2007cited by this paper
• Polycystic ovary syndrome

  2007cited by this paper
• The Physiology and Pathology of the Female Reproductive Axis

  2007cited by this paper
• Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.

  2006cited by this paper
• Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome.

  2006cited by this paper
• Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS)

  2005cited by this paper
• Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment.

  2005cited by this paper
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

  2004cited by this paper
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

  2004cited by this paper
• Standards of medical care in diabetes.

  2004cited by this paper
• Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents.

  2003cited by this paper
• A critical evaluation of simple methods for the estimation of free testosterone in serum.

  1999cited by this paper
• Insulin resistance in polycystic ovary syndrome

  1997cited by this paper
• Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome

  1997cited by this paper
• Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy.

  1994cited by this paper
• A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome.

  1991cited by this paper
• Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.

  1990cited by this paper
• Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome

  1990cited by this paper
• Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome.

  1989cited by this paper
• Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin.

  1988cited by this paper
• Determination of the source(s) of androgen overproduction in hirsutism associated with polycystic ovary syndrome by simultaneous adrenal and ovarian venous catheterization. Comparison with the dexamethasone suppression test.

  1986cited by this paper
• Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

  1985influential reference
• Specific insulin binding sites in human ovary.

  1984cited by this paper
• Insulin Stimulates Androgen Accumulation in Incubations of Human Ovarian Stroma and Theca

  1984cited by this paper
• Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease.

  1980cited by this paper
• The polycystic ovary. III. Steroid biosynthesis in normal and polycystic ovarian tissue.

  1962cited by this paper
• Clinical assessment of body hair growth in women.

  1961cited by this paper
• Amenorrhea associated with bilateral polycystic ovaries

  1935cited by this paper
• 0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(6):2745–2749 Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/jc.2003-032046 The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected

  year unknowncited by this paper

• Metabolic syndrome and dermatological diseases: association and treatment

  2025cites this paper
• Association Between Serum Antinuclear Antibody and Polycystic Ovarian Syndrome in Reproductive Women Aged 18 to 35 Years: A Quest for an Autoimmune Marker

  2024cites this paper
• Skin as a mirror of metabolic syndrome: Do some dermatoses alarm internal metabolic sinister?

  2024cites this paper
• Oxidative stress and metabolic syndrome in acne vulgaris: Pathogenetic connections and potential role of dietary supplements and phytochemicals.

  2023cites this paper
• Plasma-free metanephrines, nerve growth factor, and renalase significance in patients with PCOS

  2023cites this paper
• Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review

  2022cites this paper
• Impact of metabolic disorders on endometrial receptivity in patients with polycystic ovary syndrome.

  2022cites this paper
• Skin and metabolic syndrome: A review of the possible associations

  2021cites this paper
• Evaluation of the Efficacy of Sex Hormone–Binding Globulin in Insulin Resistance Assessment Based on HOMA-IR in Patients with PCOS

  2021cites this paper
• Efficacy of sex hormone-binding globulin on predicting metabolic syndrome in newly diagnosed and untreated patients with polycystic ovary syndrome

  2020cites this paper
• Chronic systemic inflammation in pathways of metabolic syndrome associated with hyperandrogenism (review)

  2020cites this paper
• LKB1 suppresses androgen synthesis in a mouse model of hyperandrogenism via IGF‐1 signaling

  2019cites this paper
• Circulating Angiopoietin-like 8 protein (ANGPTL8/Betatrophin) in patients with polycystic ovary syndrome: a systematic review and multi effect size meta-analysis

  2019cites this paper
• The association between digit ratio (2D:4D) and the first spermatorrhea among Chinese boys.

  2018cites this paper
• Evaluation of serum anti-nuclear antibody among women with PCOS: a hospital based single center cross sectional study

  2018cites this paper
• Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients

  2018cites this paper